These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21876505)

  • 1. Hormonal regulators of food intake and weight gain in Parkinson's disease after subthalamic nucleus stimulation.
    Novakova L; Haluzik M; Jech R; Urgosik D; Ruzicka F; Ruzicka E
    Neuro Endocrinol Lett; 2011; 32(4):437-41. PubMed ID: 21876505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ghrelin, neuropeptide Y and leptin peptides in weight gain after deep brain stimulation for Parkinson's disease.
    Markaki E; Ellul J; Kefalopoulou Z; Trachani E; Theodoropoulou A; Kyriazopoulou V; Constantoyannis C
    Stereotact Funct Neurosurg; 2012; 90(2):104-12. PubMed ID: 22398667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in body weight is a non-motor side effect of deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Novakova L; Ruzicka E; Jech R; Serranova T; Dusek P; Urgosik D
    Neuro Endocrinol Lett; 2007 Feb; 28(1):21-5. PubMed ID: 17277730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.
    Sauleau P; Leray E; Rouaud T; Drapier S; Drapier D; Blanchard S; Drillet G; Péron J; Vérin M
    Mov Disord; 2009 Oct; 24(14):2149-55. PubMed ID: 19735089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term follow-up of weight changes in subthalamic nucleus stimulated Parkinson's disease patients.
    Foubert-Samier A; Maurice S; Hivert S; Guelh D; Rigalleau V; Burbaud P; Cuny E; Meissner W; Tison F
    Rev Neurol (Paris); 2012 Feb; 168(2):173-6. PubMed ID: 22019230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diurnal variation of hypothalamic function and chronic subthalamic nucleus stimulation in Parkinson's disease.
    Seifried C; Boehncke S; Heinzmann J; Baudrexel S; Weise L; Gasser T; Eggert K; Fogel W; Baas H; Badenhoop K; Steinmetz H; Hilker R
    Neuroendocrinology; 2013; 97(3):283-90. PubMed ID: 23051911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subthalamic nucleus stimulation affects incentive salience attribution in Parkinson's disease.
    Serranová T; Jech R; Dušek P; Sieger T; Růžička F; Urgošík D; Růžička E
    Mov Disord; 2011 Oct; 26(12):2260-6. PubMed ID: 21780183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change of the melanocortin system caused by bilateral subthalamic nucleus stimulation in Parkinson's disease.
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Sáez-Zea C; Jouma-Katati M; Piédrola-Maroto G; Ramírez-Navarro A; Mínguez-Castellanos A
    Acta Neurol Scand; 2011 Oct; 124(4):275-81. PubMed ID: 21198450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free-living energy expenditure reduced after deep brain stimulation surgery for Parkinson's disease.
    Jorgensen HU; Werdelin L; Lokkegaard A; Westerterp KR; Simonsen L
    Clin Physiol Funct Imaging; 2012 May; 32(3):214-20. PubMed ID: 22487156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic stress-like syndrome as a consequence of medial site subthalamic stimulation in Parkinson's disease.
    Růžička F; Jech R; Nováková L; Urgošík D; Bezdíček O; Vymazal J; Růžička E
    Psychoneuroendocrinology; 2015 Feb; 52():302-10. PubMed ID: 25554999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single electrode and multiple electrode guided electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Temel Y; Wilbrink P; Duits A; Boon P; Tromp S; Ackermans L; van Kranen-Mastenbroek V; Weber W; Visser-Vandewalle V
    Neurosurgery; 2007 Nov; 61(5 Suppl 2):346-55; discussion 355-7. PubMed ID: 18091250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight gain rate in patients with Parkinson's disease and deep brain stimulation.
    Barichella M; Marczewska AM; Mariani C; Landi A; Vairo A; Pezzoli G
    Mov Disord; 2003 Nov; 18(11):1337-40. PubMed ID: 14639677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight changes in Parkinson's disease patients after subthalamic nucleus deep brain stimulation surgery.
    Moghaddasi M; Boshtam M
    Acta Neurol Belg; 2010 Dec; 110(4):311-3. PubMed ID: 21305860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.
    Tsai ST; Lin SH; Chou YC; Pan YH; Hung HY; Li CW; Lin SZ; Chen SY
    Stereotact Funct Neurosurg; 2009; 87(4):241-8. PubMed ID: 19556833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.